Lavipharm

Lavipharm PP&E per Employee

The PP&E per Employee of Lavipharm (LAVI.AT) as of Nov 2, 2026 is 92,695.65 EUR. In the previous year, PP&E per Employee was 95,461.96 EUR — a change of -2.90% (lower).

PP&E per Employee

92,695.65EUR

YoY

-2.90%

Last updated:

PP&E per Employee of Lavipharm is 2022 92,695.65 EUR. PP&E per Employee of Lavipharm was 2021 95,461.96 EUR. It decreases by -2.90% lower compared to the previous year.

The Lavipharm PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2015
121,760.87 EUR
Jan 1, 2016
101,059.78 EUR
Jan 1, 2017
83,021.74 EUR
Jan 1, 2018
83,309.78 EUR
Jan 1, 2019
93,413.04 EUR
Jan 1, 2020
92,657.61 EUR
Jan 1, 2021
95,461.96 EUR
Jan 1, 2022
92,695.65 EUR
The Lavipharm PP&E per Employee history
YEARPP&E per EmployeeYoY
92,695.65EUR-2.90%
95,461.96EUR+3.03%
92,657.61EUR-0.81%
93,413.04EUR+12.13%
83,309.78EUR+0.35%
83,021.74EUR-17.85%
101,059.78EUR-17.00%
121,760.87EUR+8.99%
111,714.42EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lavipharm Stock analysis

What does Lavipharm do? Lavipharm SA manufactures and imports pharmaceuticals and veterinary products, with main categories including anti-inflammatory, asthma controlling, neurological, antiseptic, analgesic, dermatological, and gastrointestinal therapies. The company offers cosmetic products under the brands Castalia Soins Dermocosmetiques and Laviderm Active Technology for skin, face, body, scalp, and hair care. Its OTC products encompass cold and flu remedies, oral care, dermatological items, condoms, antiseptics, analgesics, laxatives, and gynecology products. The company is the parent of Lavipharm Group of Companies and previously sold HITEX, a carbon dioxide extraction subcontracting business, to Robertet SA and CODIF in January 2014. Lavipharm SA's revenue streams come from the sale of pharmaceuticals, veterinary products, cosmetics under Castalia and Laviderm, and OTC products. Pharmaceutical and veterinary products target healthcare providers and pharmacies, while cosmetics and OTC products are sold directly to consumers through retail channels. The company's brand portfolio includes Castalia Soins Dermocosmetiques, Laviderm Active Technology, and its core pharmaceutical lines, with segments defined by product categories and distribution channels. The company's primary customers are healthcare professionals and retail consumers, with pharmaceuticals distributed via pharmacies and veterinary products to animal care facilities. Cosmetic products under Castalia and Laviderm are sold to consumers for personal care, and OTC products reach consumers through general retail. The sale of HITEX to Robertet SA and CODIF in 2014 was a one-time transaction that contributed to the company's financials during that period. Lavipharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lavipharm stock

PP&E per Employee of Lavipharm is 92,695.65 EUR in 2022.

PP&E per Employee of Lavipharm changed from 95,461.96 EUR to 92,695.65 EUR, representing a -2.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee Lavipharm since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's Lavipharm historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Lavipharm

All Key Metrics — Lavipharm